RESUMO
Neutrophil elastase (NE) and cathepsin G (CG) contribute to intracellular microbial killing but, if left unchecked and released extracellularly, promote tissue damage. Conversely, mechanisms that constrain neutrophil serine protease activity protect against tissue damage but may have the untoward effect of disabling the microbial killing arsenal. The host elaborates thrombospondin-1 (TSP-1), a matricellular protein released during inflammation, but its role during neutrophil activation following microbial pathogen challenge remains uncertain. Mice deficient in TSP-1 (thbs1(-/-)) showed enhanced lung bacterial clearance, reduced splenic dissemination, and increased survival compared with wild-type (WT) controls during intrapulmonary Klebsiella pneumoniae infection. More effective pathogen containment was associated with reduced burden of inflammation in thbs1(-/-) mouse lungs compared with WT controls. Lung NE activity was increased in thbs1(-/-) mice following K. pneumoniae challenge, and thbs1(-/-) neutrophils showed enhanced intracellular microbial killing that was abrogated with recombinant TSP-1 administration or WT serum. Thbs1(-/-) neutrophils exhibited enhanced NE and CG enzymatic activity, and a peptide corresponding to amino-acid residues 793-801 within the type-III repeat domain of TSP-1 bridled neutrophil proteolytic function and microbial killing in vitro. Thus, TSP-1 restrains proteolytic action during neutrophilic inflammation elicited by K. pneumoniae, providing a mechanism that may regulate the microbial killing arsenal.
Assuntos
Imunidade Inata , Infecções por Klebsiella/imunologia , Infecções por Klebsiella/metabolismo , Klebsiella pneumoniae/imunologia , Neutrófilos/imunologia , Neutrófilos/metabolismo , Serina Proteases/metabolismo , Trombospondina 1/metabolismo , Animais , Catepsina G/metabolismo , Citotoxicidade Imunológica , Modelos Animais de Doenças , Infecções por Klebsiella/mortalidade , Infecções por Klebsiella/patologia , Elastase de Leucócito/metabolismo , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/microbiologia , Pulmão/patologia , Camundongos , Camundongos Knockout , Neutrófilos/efeitos dos fármacos , Peptídeos/farmacologia , Proteínas Recombinantes/farmacologia , Explosão Respiratória/genética , Explosão Respiratória/imunologia , Baço/imunologia , Baço/metabolismo , Baço/microbiologia , Trombospondina 1/química , Trombospondina 1/deficiência , Trombospondina 1/genética , Trombospondina 1/farmacologiaRESUMO
Efferocytosis is believed to be a key regulator for lung inflammation in chronic obstructive pulmonary disease. In this study we pharmacologically inhibited efferocytosis with annexin V and attempted to determine its impact on the progression of pulmonary emphysema in mouse. We first demonstrated in vitro and in vivo efferocytosis experiments using annexin V, an inhibitor for phosphatidylserine-mediated efferocytosis. We then inhibited efferocytosis in porcine pancreatic elastase (PPE)-treated mice. PPE-treated mice were instilled annexin V intranasally starting from day 8 until day 20. Mean linear intercept (Lm) was measured, and cell apoptosis was assessed in lung specimen obtained on day 21. Cell profile, apoptosis, and mRNA expression of matrix metalloproteinases (MMPs) and growth factors were evaluated in bronchoalveolar lavage (BAL) cells on day 15. Annexin V attenuated macrophage efferocytosis both in vitro and in vivo. PPE-treated mice had a significant higher Lm, and annexin V further increased that by 32%. More number of macrophages was found in BAL fluid in this group. Interestingly, cell apoptosis was not increased by annexin V treatment both in lung specimens and BAL fluid, but macrophages from mice treated with both PPE and annexin V expressed higher MMP-2 mRNA levels and had a trend for higher MMP-12 mRNA expression. mRNA expression of keratinocyte growth factor tended to be downregulated. We showed that inhibited efferocytosis with annexin V worsened elastase-induced pulmonary emphysema in mice, which was, at least partly, attributed to a lack of phenotypic change in macrophages toward anti-inflammatory one.
Assuntos
Anexina A5/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Macrófagos Alveolares/enzimologia , Elastase Pancreática/efeitos adversos , Enfisema Pulmonar/tratamento farmacológico , Animais , Apoptose/efeitos dos fármacos , Lavagem Broncoalveolar , Feminino , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Humanos , Macrófagos Alveolares/patologia , Metaloproteinase 12 da Matriz/biossíntese , Metaloproteinase 2 da Matriz/biossíntese , Camundongos , Elastase Pancreática/farmacologia , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/enzimologia , Doença Pulmonar Obstrutiva Crônica/patologia , Enfisema Pulmonar/induzido quimicamente , Enfisema Pulmonar/enzimologia , Enfisema Pulmonar/patologia , RNA Mensageiro/biossíntese , SuínosRESUMO
Exacerbations of chronic obstructive pulmonary disease (COPD) reduce quality of life and increase mortality. Genetic variation might explain the substantial variability seen in exacerbation frequency among COPD subjects with similar lung function. Polymorphisms in five candidate genes, previously associated with COPD susceptibility, were analysed in order to determine whether they demonstrated association with COPD exacerbations. A total of 88 single nucleotide polymorphisms (SNPs) in the genes microsomal epoxide hydrolase (EPHX1), transforming growth factor, beta-1 (TGFB1), serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2), glutathione S-transferase pi (GSTP1) and surfactant protein B (SFTPB) were genotyped in 389 non-Hispanic white participants in the National Emphysema Treatment Trial. Exacerbations were defined as COPD-related emergency room visits or hospitalisations using the Centers for Medicare and Medicaid Services claims data. One or more exacerbations were experienced by 216 (56%) subjects during the study period. An SFTPB promoter polymorphism, rs3024791, was associated with COPD exacerbations. Logistic regression models, analysing a binary outcome of presence or absence of exacerbations, confirmed the association of rs3024791 with COPD exacerbations. Negative binomial regression models demonstrated association of multiple SFTPB SNPs (rs2118177, rs2304566, rs1130866 and rs3024791) with exacerbation rates. Polymorphisms in EPHX1, GSTP1, TGFB1 and SERPINE2 did not demonstrate association with COPD exacerbations. In conclusion, genetic variation in surfactant protein B is associated with chronic obstructive pulmonary disease susceptibility and exacerbation frequency.
Assuntos
Polimorfismo Genético , Doença Pulmonar Obstrutiva Crônica/genética , Proteína B Associada a Surfactante Pulmonar/genética , Idoso , Alelos , Feminino , Predisposição Genética para Doença , Variação Genética , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Análise de Regressão , FumarRESUMO
Animal models play an important role in the understanding of the pathogenesis of chronic obstructive pulmonary disease (COPD). The applicability of findings to human COPD depends upon several factors, including the disease model, and similarities in mouse structure and function between species. There are many examples in the literature of transgenic mice that have contributed to the understanding of COPD. Several studies demonstrate the complexity of inflammatory networks and how unexpected findings in animal models have led to the search for new potential mediators in human disease. Gene-targeting studies into alpha(1)-antitrypsin (alpha(1)-AT) and emphysema in mice have demonstrated that the genetic locus for alpha(1)-AT in mice is very complex and that the loss of one gene is lethal in embryo lung development. This underlines the differences between mice and humans that limit the ability to translate between systems in some instances. Gene targeting has also highlighted complex roles for transforming growth factor-beta in COPD and has been used to determine important molecules and pathways in COPD. Both transgenic and gene-targeted models suffer limitations and their applicability to human chronic obstructive pulmonary disease may be dependant on several factors, some of which are still being learnt. The more that is known about similarities and differences, the better the knowledge will be that is gained to develop for chronic obstructive pulmonary disease.
Assuntos
Modelos Animais de Doenças , Marcação de Genes , Camundongos/genética , Doença Pulmonar Obstrutiva Crônica/genética , Fator de Crescimento Transformador beta/genética , alfa 1-Antitripsina/genética , Animais , Camundongos Mutantes , Camundongos TransgênicosRESUMO
Activating mutations in K-ras are one of the most common genetic alterations in human lung cancer. To dissect the role of K-ras activation in bronchial epithelial cells during lung tumorigenesis, we created a model of lung adenocarcinoma by generating a conditional mutant mouse with both Clara cell secretory protein (CC10)-Cre recombinase and the Lox-Stop-Lox K-ras(G12D) alleles. The activation of K-ras mutant allele in CC10 positive cells resulted in a progressive phenotype characterized by cellular atypia, adenoma and ultimately adenocarcinoma. Surprisingly, K-ras activation in the bronchiolar epithelium is associated with a robust inflammatory response characterized by an abundant infiltration of alveolar macrophages and neutrophils. These mice displayed early mortality in the setting of this pulmonary inflammatory response with a median survival of 8 weeks. Bronchoalveolar lavage fluid from these mutant mice contained the MIP-2, KC, MCP-1 and LIX chemokines that increased significantly with age. Cell lines derived from these tumors directly produced MIP-2, LIX and KC. This model demonstrates that K-ras activation in the lung induces the elaboration of inflammatory chemokines and provides an excellent means to further study the complex interactions between inflammatory cells, chemokines and tumor progression.
Assuntos
Genes ras , Neoplasias Pulmonares/genética , Pneumonia/genética , Animais , Sequência de Bases , Líquido da Lavagem Broncoalveolar , Linhagem Celular Tumoral , Primers do DNA , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/fisiopatologia , Macrófagos Alveolares/patologia , Camundongos , Camundongos Mutantes , Pneumonia/complicações , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
OBJECTIVE AND DESIGN: Chronic obstructive pulmonary disease (COPD) is characterized by an inflammatory process and airway remodeling involving matrix metalloproteinases (MMPs). Thus, we analyzed the expression and release of MMP-12 (macrophage metalloelastase) in bronchoalveolar lavage (BAL) and lung tissue from COPD patients and control subjects. METHODS: Immunocytochemistry and immunochemistry were performed to analyze the expression of MMP-12 in BAL cells and bronchial biopsies. Western blotting was used for the evaluation of MMP-12 in BAL fluids. RESULTS: The number of MMP-12 expressing macrophages together with the staining intensity was higher in BAL samples from COPD patients than in controls subjects. Similar results were noted in bronchial biopsies with higher MMP-12 expression in COPD subjects than in controls. Enhanced MMP-12 level was also observed in BAL fluids from patient with COPD in comparison to control subjects. CONCLUSION: This study demonstrated that COPD patients produce greater quantities of MMP-12 than controls, which may be a critical step in the pathogenesis of COPD and emphysema.
Assuntos
Pulmão/enzimologia , Metaloendopeptidases/metabolismo , Doença Pulmonar Obstrutiva Crônica/enzimologia , Biópsia , Líquido da Lavagem Broncoalveolar/química , Líquido da Lavagem Broncoalveolar/citologia , Feminino , Humanos , Pulmão/patologia , Masculino , Metaloproteinase 12 da Matriz , Pessoa de Meia-Idade , Doença Pulmonar Obstrutiva Crônica/patologiaAssuntos
Endopeptidases/metabolismo , Metaloproteinases da Matriz/metabolismo , Inibidores de Proteases/farmacologia , Doença Pulmonar Obstrutiva Crônica/etiologia , Animais , Movimento Celular/efeitos dos fármacos , Movimento Celular/fisiologia , Enfisema/enzimologia , Enfisema/etiologia , Humanos , Metaloproteinases da Matriz/efeitos dos fármacos , Camundongos , Inibidores de Proteases/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/enzimologia , Sensibilidade e EspecificidadeRESUMO
Chronic obstructive pulmonary disease is a leading cause of death and disability, but has only recently been extensively explored from a cellular and molecular perspective. There is a chronic inflammation that leads to fixed narrowing of small airways and alveolar wall destruction (emphysema). This is characterised by increased numbers of alveolar macrophages, neutrophils and cytotoxic T-lymphocytes, and the release of multiple inflammatory mediators (lipids, chemokines, cytokines, growth factors). A high level of oxidative stress may amplify this inflammation. There is also increased elastolysis and evidence for involvement of several elastolytic enzymes, including serine proteases, cathepsins and matrix metalloproteinases. The inflammation and proteolysis in chronic obstructive pulmonary disease is an amplification of the normal inflammatory response to cigarette smoke. This inflammation, in marked contrast to asthma, appears to be resistant to corticosteroids, prompting a search for novel anti-inflammatory therapies that may prevent the relentless progression of the disease.
Assuntos
Imunidade Celular/fisiologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Humanos , Doença Pulmonar Obstrutiva Crônica/metabolismoRESUMO
The use of genetically manipulated mice together with traditional animal studies are steadily increasing our knowledge of the factors important in determining alveolar formation and destruction in emphysema. A review of the animal models used to study emphysema is presented.
Assuntos
Modelos Animais de Doenças , Doença Pulmonar Obstrutiva Crônica/etiologia , Enfisema Pulmonar/etiologia , Animais , Marcação de Genes , Engenharia Genética , Camundongos , Camundongos Mutantes , Camundongos Transgênicos , Mutação/genética , Enfisema Pulmonar/induzido quimicamenteRESUMO
Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, and we have little specific therapy to offer these patients. One potential strategy to limit loss of lung function in COPD would be to inhibit matrix-degrading proteinases. Several serine proteinases and matrix metalloproteinases are expressed in association with COPD in humans. Application of gene-targeted macrophage elastase and neutrophil elastase to a mouse model of cigarette-smoke-induced emphysema has uncovered roles for these proteinases in airspace enlargement, and has identified many interactions between these proteolytic systems.
Assuntos
Endopeptidases/metabolismo , Doença Pulmonar Obstrutiva Crônica/enzimologia , Animais , Brônquios/enzimologia , Cisteína Endopeptidases/metabolismo , Humanos , Metaloproteinases da Matriz/metabolismo , Camundongos , Alvéolos Pulmonares/enzimologia , Doença Pulmonar Obstrutiva Crônica/etiologia , Doença Pulmonar Obstrutiva Crônica/patologia , Serina Endopeptidases/metabolismoRESUMO
MNEI (monocyte/neutrophil elastase inhibitor) is a 42 kDa serpin superfamily protein characterized initially as a fast-acting inhibitor of neutrophil elastase. Here we show that MNEI has a broader specificity, efficiently inhibiting proteases with elastase- and chymotrypsin-like specificities. Reaction of MNEI with neutrophil proteinase-3, an elastase-like protease, and porcine pancreatic elastase demonstrated rapid inhibition rate constants >10(7) M(-1) s(-1), similar to that observed for neutrophil elastase. Reactions of MNEI with chymotrypsin-like proteases were also rapid: cathepsin G from neutrophils (>10(6) M(-1) s(-1)), mast cell chymase (>10(5) M(-1) s(-1)), chymotrypsin (>10(6) M(-1) s(-1)), and prostate-specific antigen (PSA), which had the slowest rate constant at approximately 10(4) M(-1) s(-1). Inhibition of trypsin-like (plasmin, granzyme A, and thrombin) and caspase-like (granzyme B) serine proteases was not observed or highly inefficient (trypsin), nor was inhibition of proteases from the cysteine (caspase-1 and caspase-3) and metalloprotease (macrophage elastase, MMP-12) families. The stoichiometry of inhibition for all inhibitory reactions was near 1, and inhibitory complexes were resistant to dissociation by SDS, further indicating the specificity of MNEI for elastase- and chymotrypsin-like proteases. Determination of the reactive site of MNEI by N-terminal sequencing and mass analysis of reaction products identified two reactive sites, each with a different specificity. Cys(344), which corresponds to Met(358), the P(1) site of alpha1-antitrypsin, was the inhibitory site for elastase-like proteases and PSA, while the preceding residue, Phe(343), was the inhibitory site for chymotrypsin-like proteases. This study demonstrates that MNEI has two functional reactive sites corresponding to the predicted P(1) and P(2) positions of the reactive center loop. The data suggest that MNEI plays a regulatory role at extravascular sites to limit inflammatory damage due to proteases of cellular origin.
Assuntos
Quimotripsina/antagonistas & inibidores , Elastase Pancreática/antagonistas & inibidores , Proteínas/metabolismo , Proteínas/farmacologia , Inibidores de Serina Proteinase/metabolismo , Inibidores de Serina Proteinase/farmacologia , Serpinas/farmacologia , Animais , Sítios de Ligação , Catepsina G , Catepsinas/antagonistas & inibidores , Catepsinas/metabolismo , Quimases , Quimotripsina/metabolismo , Cisteína/metabolismo , Humanos , Cinética , Elastase de Leucócito/antagonistas & inibidores , Elastase de Leucócito/metabolismo , Mieloblastina , Elastase Pancreática/metabolismo , Fragmentos de Peptídeos/metabolismo , Fragmentos de Peptídeos/farmacologia , Fenilalanina/metabolismo , Antígeno Prostático Específico/antagonistas & inibidores , Antígeno Prostático Específico/metabolismo , Serina Endopeptidases/metabolismo , Serpinas/metabolismo , Especificidade por Substrato , SuínosRESUMO
Despite much information on their catalytic properties and gene regulation, we actually know very little of what matrix metalloproteinases (MMPs) do in tissues. The catalytic activity of these enzymes has been implicated to function in normal lung biology by participating in branching morphogenesis, homeostasis, and repair, among other events. Overexpression of MMPs, however, has also been blamed for much of the tissue destruction associated with lung inflammation and disease. Beyond their role in the turnover and degradation of extracellular matrix proteins, MMPs also process, activate, and deactivate a variety of soluble factors, and seldom is it readily apparent by presence alone if a specific proteinase in an inflammatory setting is contributing to a reparative or disease process. An important goal of MMP research will be to identify the actual substrates upon which specific enzymes act. This information, in turn, will lead to a clearer understanding of how these extracellular proteinases function in lung development, repair, and disease.
Assuntos
Pulmão/fisiologia , Metaloproteinases da Matriz/fisiologia , Animais , Humanos , Metaloproteinase 12 da Matriz , Metaloproteinase 7 da Matriz/fisiologia , Metaloendopeptidases/fisiologia , Especificidade por SubstratoRESUMO
Acute and fulminant liver failure induced by viral hepatitis, alcohol or other hepatotoxic drugs, are associated with tumor necrosis factor (TNF) production. In a mouse model of lethal hepatitis induced by TNF, apoptosis and necrosis of hepatocytes, but also lethality, hypothermia and influx of leukocytes into the liver, are prevented by a broad-spectrum matrix metalloproteinase (MMP) inhibitor, BB-94. Mice deficient in MMP-2, MMP-3 or MMP-9 had lower levels of apoptosis and necrosis of hepatocytes, and better survival. We found induction of MMP-9 activity and fibronectin degradation. Our findings suggest that several MMPs play a critical role in acute, fulminant hepatitis by degrading the extracellular matrix and allowing massive leukocyte influx in the liver. BB-94 also prevented lethality in TNF/interferon-gamma therapy in tumor-bearing mice. A broad-spectrum MMP inhibitor may be potentially useful for the treatment of patients with acute and perhaps chronic liver failure, and in cancer therapies using inflammatory cytokines.
Assuntos
Hepatite Animal/prevenção & controle , Inibidores de Metaloproteinases de Matriz , Fenilalanina/análogos & derivados , Animais , Apoptose/efeitos dos fármacos , Hepatite Animal/induzido quimicamente , Hepatite Animal/enzimologia , Hepatite Animal/patologia , Humanos , Interferon gama/uso terapêutico , Interferon gama/toxicidade , Metaloproteinases da Matriz/deficiência , Metaloproteinases da Matriz/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neoplasias/tratamento farmacológico , Fenilalanina/farmacologia , Inibidores de Proteases/farmacologia , Proteínas Recombinantes , Tiofenos/farmacologia , Fator de Necrose Tumoral alfa/uso terapêutico , Fator de Necrose Tumoral alfa/toxicidadeRESUMO
BACKGROUND/AIMS: Tumor necrosis factor (TNF) plays an essential role in several types of acute and chronic hepatitis. Our aims in the present study were to elucidate the mechanism by which TNF leads to acute lethal hepatitis, thereby focusing on the role of serine proteases and platelet-activating factor (PAF). METHODS: All experiments were performed in a model of acute hepatitis, induced by TNF in combination with D-(+)-galactosamine (GalN). Neutrophil elastase (NE)-deficient mice, generated by gene targeting were used in the studies. RESULTS: We found that a serine protease plays an essential mediating role in the in vivo TNF effect as alpha1-antitrypsin (alpha1-AT), soybean trypsin inhibitor (STI) and turkey trypsin inhibitor (TTI), confer complete protection. alpha1-AT and TTI, but not STI, reduce PAF blood levels, induced by TNF/GalN, which is compatible with an elastase-like serine protease involvement in PAF synthesis. In our search for relevant serine proteases we believed that NE was an excellent candidate protease. However, we found that TNF/GalN-induced lethality is not attenuated in mice deficient in NE. CONCLUSIONS: The data suggest that TNF-induced lethal hepatitis is accompanied by increases in circulating PAF and plasma clotting time, and mediated by a serine protease, but not by NE.
Assuntos
Doença Hepática Induzida por Substâncias e Drogas/sangue , Doença Hepática Induzida por Substâncias e Drogas/mortalidade , Fator de Ativação de Plaquetas/metabolismo , Serina Endopeptidases/fisiologia , Fator de Necrose Tumoral alfa , Doença Aguda , Animais , Combinação de Medicamentos , Galactosamina , Elastase de Leucócito/genética , Elastase de Leucócito/fisiologia , Lipopolissacarídeos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout/genéticaRESUMO
Recent studies strongly suggest that surfactant protein D (SP-D) plays important roles in pulmonary host defense and the regulation of immune and inflammatory reactions in the lung. Although SP-D can bind to alveolar macrophages and can elicit their chemotaxis, relatively little is known about the direct cellular consequences of SP-D on the function of these cells. Because matrix metalloproteinases (MMPs) are synthesized in increased amounts in response to various proinflammatory stimuli, we investigated the capacity of SP-D to modulate the production of MMPs by freshly isolated human alveolar macrophages. Unexpectedly we found that recombinant rat SP-D dodecamers selectively induce the biosynthesis of collagenase-1 (MMP-1), stromelysin (MMP-3), and macrophage elastase (MMP-12) without significantly increasing the production of tumor necrosis factor alpha and interleukin-1beta. SP-D did not alter the production of these MMPs by fibroblasts. Phosphatidylinositol, a surfactant-associated ligand that interacts with the carboxyl-terminal neck and carbohydrate recognition domains of SP-D, inhibited the SP-D-dependent increase in MMP biosynthesis. A trimeric, recombinant protein consisting of only the neck and carbohydrate recognition domain did not augment metalloproteinase production, suggesting that the stimulatory effect on MMP production depends on an appropriate spatial presentation of trimeric lectin domains. Although SP-D dodecamers can selectively augment metalloproteinase activity in vitro, this effect may be competitively inhibited by tissue inhibitors of metalloproteinases or surfactant-associated ligands in vivo.
Assuntos
Glicoproteínas/farmacologia , Macrófagos Alveolares/efeitos dos fármacos , Metaloproteinases da Matriz/biossíntese , Surfactantes Pulmonares/farmacologia , Animais , Biopolímeros , Células CHO , Cricetinae , Indução Enzimática , Glicoproteínas/antagonistas & inibidores , Macrófagos Alveolares/enzimologia , Fosfatidilinositóis/farmacologia , Proteína D Associada a Surfactante Pulmonar , Surfactantes Pulmonares/antagonistas & inibidores , Ratos , Proteínas Recombinantes/antagonistas & inibidores , Proteínas Recombinantes/farmacologiaRESUMO
BACKGROUND: Chronic hypoxia results in the development of pulmonary hypertension and subsequent right heart failure. A role of the plasminogen system in the pathogenesis of pulmonary hypertension and pulmonary vascular remodeling has been suggested. METHODS AND RESULTS: Mice with targeted deficiency of the gene encoding tissue-type plasminogen activator (t-PA(-/-)), urokinase-type plasminogen activator (u-PA(-/-)), u-PA receptor (u-PAR(-/-)), or plasminogen (plg(-/-)) were subjected to hypoxic conditions. Hypoxia caused a significant 2.5-fold rise in right ventricular pressure in wild-type mice. Deficiency of u-PA or plasminogen prevented this increase in right ventricular pressure, t-PA(-/-) mice showed changes that were fully comparable with wild-type mice, and u-PAR(-/-) mice showed a partial response. Hypoxia induced an increase in smooth muscle cells within pulmonary arterial walls and a vascular rarefaction in the lungs of wild-type but not of u-PA(-/-) or plg(-/-) mice. Elastic lamina fragmentation, observed in hypoxic wild-type but not in u-PA or plasminogen-deficient mice, suggested that proliferation of vascular smooth muscle cells was dependent on u-PA-mediated elastic membrane degradation. Hypoxia-induced right ventricular remodeling in wild-type mice, characterized by cardiomyocyte hypertrophy and increased collagen contents, was not seen in u-PA(-/-) and plg(-/-) mice. CONCLUSIONS: Loss of the u-PA or plasminogen gene protects against the development of hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling. These observations point to an essential role of u-PA-mediated plasmin generation in the adaptive response to chronic hypoxia and the occurrence of hypoxic pulmonary vascular disease.
Assuntos
Hipertensão Pulmonar/metabolismo , Hipóxia/metabolismo , Plasminogênio/biossíntese , Circulação Pulmonar , Ativador de Plasminogênio Tipo Uroquinase/deficiência , Animais , Animais Recém-Nascidos , Artérias/metabolismo , Artérias/patologia , Peso Corporal , Hemodinâmica/genética , Hipertensão Pulmonar/etiologia , Hipertensão Pulmonar/patologia , Hipertensão Pulmonar/fisiopatologia , Hipertrofia Ventricular Direita/etiologia , Hipertrofia Ventricular Direita/metabolismo , Hipertrofia Ventricular Direita/patologia , Hipóxia/complicações , Hipóxia/fisiopatologia , Pulmão/irrigação sanguínea , Pulmão/metabolismo , Pulmão/patologia , Metaloproteinase 9 da Matriz/metabolismo , Camundongos , Camundongos Transgênicos , Músculo Liso Vascular/patologia , Miocárdio/metabolismo , Miocárdio/patologia , Tamanho do Órgão , Plasminogênio/deficiência , Plasminogênio/genética , Circulação Pulmonar/genética , Circulação Pulmonar/fisiologia , Receptores de Superfície Celular/deficiência , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/metabolismo , Receptores de Ativador de Plasminogênio Tipo Uroquinase , Ativador de Plasminogênio Tecidual/deficiência , Ativador de Plasminogênio Tecidual/genética , Ativador de Plasminogênio Tecidual/metabolismo , Ativador de Plasminogênio Tipo Uroquinase/genética , Ativador de Plasminogênio Tipo Uroquinase/metabolismoAssuntos
Metaloproteinases da Matriz/genética , Animais , Doenças Cardiovasculares/enzimologia , Doenças Cardiovasculares/genética , Dermatite de Contato/enzimologia , Dermatite de Contato/genética , Desenvolvimento Embrionário e Fetal/genética , Desenvolvimento Embrionário e Fetal/fisiologia , Enfisema/enzimologia , Enfisema/genética , Feminino , Humanos , Masculino , Glândulas Mamárias Animais/enzimologia , Glândulas Mamárias Animais/crescimento & desenvolvimento , Metaloproteinases da Matriz/fisiologia , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Neoplasias Experimentais/enzimologia , Neoplasias Experimentais/genética , Neovascularização Fisiológica/genética , Penfigoide Bolhoso/enzimologia , Penfigoide Bolhoso/genética , Fenótipo , Gravidez , Esteroides/biossíntese , Inibidores Teciduais de Metaloproteinases/genética , Inibidores Teciduais de Metaloproteinases/fisiologia , Cicatrização/genética , Cicatrização/fisiologiaRESUMO
Matrix metalloproteinases (MMPs) (1,2) comprise a family of over 20 matrix degrading enzymes believed to be essential for normal development and physiologic tissue remodeling and repair. Abnormal expression of metalloproteinases has been implicated in many destructive processes, including tumor cell invasion and angiogenesis, arthritis, atherosclerosis, and arterial aneurysms. With respect to lung disease, MMPs have been associated with chronic obstructive pulmonary disease (COPD), acute lung injury, pulmonary fibrosis, and asthma. The role of MMPs in causation of pulmonary emphysema has been supported by transgenic mice overexpressing MMP-1 (3) and gene targeted mice lacking MMP-12 (4).